Co-Authors
This is a "connection" page, showing publications co-authored by DIMITRIOS P KONTOYIANNIS and HARRYS ANTONIO TORRES.
Connection Strength
2.526
-
Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50.
Score: 0.518
-
Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003 Jul 01; 98(1):86-93.
Score: 0.233
-
Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8.
Score: 0.230
-
Nocardiosis in cancer patients. Medicine (Baltimore). 2002 Sep; 81(5):388-97.
Score: 0.220
-
Endemic mycoses in a cancer hospital. Medicine (Baltimore). 2002 May; 81(3):201-12.
Score: 0.215
-
Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect. 2017 12; 75(6):572-580.
Score: 0.156
-
Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85.
Score: 0.110
-
Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. J Clin Virol. 2012 Jul; 54(3):218-22.
Score: 0.107
-
Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8.
Score: 0.070
-
Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.
Score: 0.069
-
Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79.
Score: 0.068
-
Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7.
Score: 0.067
-
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis. 2005 May; 52(1):15-20.
Score: 0.066
-
Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9.
Score: 0.060
-
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21.
Score: 0.059
-
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9.
Score: 0.058
-
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
Score: 0.057
-
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26.
Score: 0.055
-
Breast implant infection caused by Trichosporon beigelii. Scand J Infect Dis. 2002; 34(2):143-4.
Score: 0.053
-
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7.
Score: 0.020
-
Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8.
Score: 0.020
-
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis. 2004 Jul 15; 39(2):192-8.
Score: 0.016